Everest Organics is currently trading at Rs. 100.90, up by 5.85 points or 6.15% from its previous closing of Rs. 95.05 on the BSE.
The scrip opened at Rs. 91.10 and has touched a high and low of Rs. 104.55 and Rs. 91.10 respectively. So far 11205 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 183.65 on 11-Jan-2018 and a 52 week low of Rs. 57.15 on 29-Oct-2018.
Last one week high and low of the scrip stood at Rs. 104.55 and Rs. 84.25 respectively. The current market cap of the company is Rs. 83.16 crore.
The promoters holding in the company stood at 73.18%, while Institutions and Non-Institutions held 0.03% and 26.79% respectively.
Telangana State Pollution Control Board (TSPCB) has inspected Everest Organics’ facility for pollution control issues and has given temporary revocation of factory closure order. The company has invested huge amount in ETP and Zero Liquid Discharge of pollutants from its facility.
Furthermore the management has initiated even more steps to make sure that the company continues to comply with all major provisions of the TSPCB in future without any minor lapses. The company is closely working with TSPCB authorities to fulfill all the documents necessary in order to have a permanent revocation order at the earliest possible.
Everest Organics is a fast growing API and Bulk drug manufacturing company with world class facility and its committed to manufacturing excellent quality products and customer service.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1666.00 |
| Dr. Reddys Lab | 1229.50 |
| Cipla | 1228.15 |
| Zydus Lifesciences | 934.00 |
| Lupin | 2329.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: